JUL 13, 2021 7:00 AM PDT

A Moment of COVID, A Lifetime of Immune Protection?

WRITTEN BY: Tara Fernandez

Does getting vaccinated, or having recovered from COVID, provide life-long protection against the coronavirus? Most likely, says research by immunologists at Washington University in St. Louis, who found antibody-producing cells against the virus residing in the bone marrow of individuals who had previously tested COVID-positive.

This discovery supports the theory that immune responses after exposure to SARS-CoV-2 are robust enough to confer sustained, potentially decades-long protection against the pathogen. In addition, this finding also indicates that vaccines may create a similarly durable shield against COVID in the long run.

Antibody-producing bone marrow plasma cells, or BMPCs, are among the body’s arsenal of immune weapons against invading pathogens, forming a part of what’s known as immunological memory. When the immune system comes across a microbiological threat that it has encountered previously, it launches a more rapid, aggressive, and targeted attack against the offending microbe the second time around.

Earlier studies had suggested that BMPC formation might not occur as effectively in COVID patients as it does in the case of other viral infections, meaning that those who have recovered from COVID may be at risk of reinfection.

However, a study led by BMPC expert Ali Ellebedy found the opposite to be true. The researchers’ analysis of samples obtained from 77 COVID-19 patients revealed that these individuals continued to produce antibodies specific to SARS-CoV-2 up to 11 months after infection. Additionally, 15 of the 18 bone marrow samples collected from these participants showed the presence of coronavirus-specific BMPCs at around a year after infection.

The scientists speculate that vaccines may elicit similar immunological responses, although the emergence of novel variants of SARS-CoV-2 may leave vaccinated individuals vulnerable and in need of “booster” shots for complete protection.

 

Source: NatureNature News.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 07, 2021
Cancer
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
OCT 07, 2021
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
Neuroblastoma is a cancer of immature nerve cells found in various areas, including the adrenal glands, neck, chest ...
OCT 14, 2021
Genetics & Genomics
RSV Infections Can Modify Host Immune Gene Activity
OCT 14, 2021
RSV Infections Can Modify Host Immune Gene Activity
Respiratory syncytial virus (RSV) are thought to be incredibly common; research has suggested that almost everyone is ev ...
NOV 18, 2021
Immunology
Could Maternal Antibodies Contribute to Autism Development?
NOV 18, 2021
Could Maternal Antibodies Contribute to Autism Development?
Pregnant mothers pass on oxygen and nutrients to their developing babies while shuttling away waste products from the fe ...
NOV 17, 2021
Health & Medicine
Nutrients for Reducing Autoimmune Disease Risk
NOV 17, 2021
Nutrients for Reducing Autoimmune Disease Risk
Want to reduce your chances of having your immune system turn on your body and start destroying your perfect health? Loo ...
NOV 25, 2021
Immunology
Battling Bacterial Pneumonia, No Antibiotics Required
NOV 25, 2021
Battling Bacterial Pneumonia, No Antibiotics Required
Instead of flooding the body with antibiotics, what if we could program cells to fight off pathogens more effectively? T ...
JAN 06, 2022
Health & Medicine
New Hope for Hair Regrowth in Alopecia Areata
JAN 06, 2022
New Hope for Hair Regrowth in Alopecia Areata
Two recently completed phase 3 clinical trials showed the drug baricitinib leads to hair growth for alopecia areata pati ...
Loading Comments...